According to Lucid Genomics, whole genome sequencing promises to transform precision medicine, gene editing, and pharmacogenomics, yet current methods often miss the "dark genome" - non-coding regions making up 98 per cent of our DNA.
Our unique strength lies in our expertise across three key areas: cutting-edge DNA sequencing technologies, advanced AI in genomics, and a deep understanding of the 'dark genome'. This powerful combination has been instrumental in founding Lucid Genomics.
We anticipate a 'Genomic Revolution' transforming healthcare, and we're committed to positioning Lucid Genomics as a pioneer in this exciting field.
Our vision is for our SaaS platform to evolve into a comprehensive digital solution capable of processing 100 per cent of any DNA sequencing data.
Collection
[
|
...
]